Check out this great informational video from #diabetes #advocate Ginger Vieira, who recently chatted with our CEO Samuel Reich to learn more about what we're doing in #t1d, and how our special cows might impact the lives of people living with #type1diabetes. https://lnkd.in/eeuhj_iS
SAB BIO
Biotechnology Research
Miami, FL 2,624 followers
We're developing a disease-modifying immunotherapy aimed at delaying the onset and progression of type 1 diabetes
About us
A clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing fully-human anti-thymocyte immunoglobulin (hIgG) for delaying the onset or progression of type 1 diabetes (T1D)
- Website
-
https://www.sab.bio/
External link for SAB BIO
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Miami, FL
- Type
- Public Company
Locations
-
Primary
Miami, FL , US
-
Sioux Falls, South Dakota, US
Employees at SAB BIO
-
Katie Ellias
Venture Capital, Biotechnology, Medical Devices, Healthcare, Board of Directors, Venture Philanthropy
-
Mark Conley
VP of Finance at SAB Biotherapeutics
-
Christoph Bausch
Executive Vice President & Chief Operating Officer, SAB Biotherapeutics
-
Mike “Batman” Cohen 🦇
Sourcer / Recruiter | Keynote Speaker | Tech Partner / Advisor | Trainer | Sponsored Pickleball Player
Updates
-
In case you missed it, we were named to The Healthcare Technology Report #top100 2024 healthcare companies last week! We're proud of our work to change patients' lives - learn more about what we're doing at the link below! https://lnkd.in/eMSVe4WG
-
Lots of great things are happening at SAB - like being named one of the Top 100 Healthcare Companies of 2024 by Healthcare Technology Report! Great to be included on this list of companies working to change patients' lives!
The Top 100 Healthcare Technology Companies of 2024 The Healthcare Technology Report is pleased to announce its annual awards for The Top 100 Healthcare Technology Companies. This year’s awardees were selected based on a methodical review of nomination submissions as well as further in-depth research into each candidate’s products and solutions, corporate track record, management team caliber, and organizational depth, among other factors. Regeneron, Medtronic, Henry Schein, Access Healthcare, LifeLabs Medical Laboratory Services, PHC Holdings Corporation, Integra LifeSciences, Lumeris, Omnicell, Globus Medical, Jazz Pharmaceuticals, Penumbra, PCI Pharma Services, Corza Medical, Aspen Medical, LivaNova, embecta, HONOR Technology, Privia Health, CareDx, Merit Medical Systems, Castle Biosciences, Endologix, Blueprint Medicines, Denali, BillionToOne, Spring Health, Ardelyx, Tebra, Zynex Medical, Tandem Diabetes Care, Biodesix, Rocket Pharma, Consensus Cloud Solutions, argenx, Rightway, Insilico Medicine, Kipu Health, Veradigm, Sutro Biopharma, SS Innovations, Promaxo, Caris Life Sciences, Burlington Medical, Phathom Pharmaceuticals, Trusted Health, Amwell, BenchSci, Heidi Health, ELEGEN., Natus Medical, Angle Health, Microbiologics, CodaMetrix, PTC Therapeutics, Livara Health, SAB BIO, Nym, Axxess, Kontakt.io, Simple App, Abcuro, Inc, Maven Clinic, Arcturus Therapeutics, Welldoc, Ostro, Sword Health, Scientist.com, Orca Bio, Bamboo Health, Omada Health, Relias, Cynerio, KLOwen Ortho, Iovance Biotherapeutics, OrthAlign, DermaSensor, Inc., PartsSource, Viz.ai, Outset Medical, Visualutions, Forward Advantage, Codonics, Intellia Therapeutics, CliniComp, Chordline Health, Jelvix, HeartFlow, Intelligencia AI, Quris AI, HMNC Brain Health, Carrot Fertility, SimpleTherapy, Casana, Vizzia Technologies, Revolution Medicines, Noah Medical, RxSight, Kestra Medical Technologies and Allurion Technologies. To view the full list visit our website: https://lnkd.in/gdphXRAS Nominate a Top Women Leaders and Top CEOs in Healthcare Technology of 2024 at https://lnkd.in/d9crSvH Sign up for our free email newsletter at https://lnkd.in/gNfBS6g #healthtech #healthcare #biotech #medicaldevices #consumerhealth #technology
-
While Nov 14 is #worlddiabetesday, people impacted by #t1d know how critically important screening, treatment, and #diabetes management is every day for people impacted by diabetes. We applaud the companies, scientists and researchers working to develop new therapies that could delay the progression of this disease, and look forward to helping rewrite the narrative of #t1d and #diabeteslife.
-
If you missed Chairman and CEO Samuel Reich at this morning's Guggenheim Securities Healthcare Innovation Conference, you can still tune into his overview of what we're doing, our upcoming milestones and how we're working to change the #innovation landscape of #T1D through the link below. https://lnkd.in/eyXMPwfR
-
Hello from Bruges! Several members of our team, including Alexandra Kropotova, MD, MBA, Christoph Bausch Ph.D, MBA, and Angela Parizek are at Immunology of Diabetes Society Annual meeting this week. SAB is a proud sponsor of this important scientific meeting hosting some of the sharpest minds working towards a #cure for #type1diabetes. Stop by our booth in the exhibit hall or come say hello to our team on-site at #ids2024!
-
Will you be attending Guggenheim Securities Healthcare Innovation Conference November 11-13? Our Chairman and #CEO, Samuel Reich, will be speaking November 11 at 3pm EST for a fireside chat. To listen in via webcast, check the link below! https://lnkd.in/eRGziNKQ
-
Great to see our incredible leadership team recognized - thanks for everything you do on behalf of people impacted by #t1d, Alexandra Kropotova, MD, MBA !
South Dakota's biotechnology community is now making waves on a global scale—and it’s continuing to expand. Join us for the 2024 South Dakota Summit & Annual Meeting to gain firsthand insights into our state’s influence on agricultural, environmental, and healthcare biotechnology around the world. Our Connecting Care Panel will share insight of how global healthcare partnerships from South Dakota are touching lives worldwide. Expert guests from OMEGAQUANT, SANFORD WORLD CLINICS, SAB BIO, and AVERA INSTITUTE FOR HUMAN GENETICS will talk about how international collaborations are enhancing healthcare innovation and delivery within South Dakota, positioning the state as a key player in global health. More info: https://lnkd.in/gJvd9rK6
-
We're having an incredible time at #EASD2024. Thank you to the European Association for the Study of Diabetes e.V. (EASD)for putting this event together. It is fantastic to learn from, connect with, and build relationships with other #type1diabetes stakeholders—see the pics of our own Christoph Bausch, PhD, MBA and Alexandra Kropotova, MD, MBA below on-site!
-
Today, we announced an important #clinicaltrial progress update at European Association for the Study of Diabetes e.V. (EASD) annual meeting. Our SAB-142 program has completed Phase 1 enrollment of all planned cohorts in healthy volunteers and is progressing to enroll patients with #type1diabetes in the last cohort of the study, with no observation of serum sickness at the targeted dose. It's an exciting year for SAB! We remain on track for a topline Phase 1 data readout by the end of the year. See link for more details in release! https://lnkd.in/eF4hT6fw